Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Prognostic, Predictive, and POC: Biomarkers from Research to Clinic

Sridhar Iyengar's Biography

Sridhar Iyengar, Founder/Director, Misfit Wearables

Sridhar Iyengar is a founder and director of Misfit Wearables, makers of highly wearable computing products, including the award-winning Shine, an elegant activity monitor. Sridhar also founded and served as CTO of AgaMatrix, a blood glucose monitoring company that made the world’s first hardware medical device to connect directly to the iPhone, winning both the Red Dot and the GOOD Design Awards. He built AgaMatrix from a two-person start-up to shipping 15+ FDA-cleared medical device products, 3B+ biosensors, 3M+ glucose meters for diabetics, with partnerships with Apple, Sanofi, and Walgreens. Whilst he still aspires to be a professional rock and roll drummer, he has put his musical endeavors on hold while he continues to invent new technologies to augment human performance through better biometric and biosensing devices. Sridhar holds over 20 US and international patents and received his Ph.D. from Cambridge University as a Marshall Scholar. Follow him on Twitter: @sridiyengar

Sridhar Iyengar Image

New Technologies Driving Mobile Point-of-Care (POC) Diagnostics

Friday, 16 January 2015 at 09:45

Add to Calendar ▼2015-01-16 09:45:002015-01-16 10:45:00Europe/LondonNew Technologies Driving Mobile Point-of-Care (POC) DiagnosticsPrognostic, Predictive, and POC: Biomarkers from Research to Clinic in San Diego, California, USASan Diego, California,

This talk will explore some of the new technologies that are being developed that bridge the traditional levels of care found in clinical settings with the convenience of mobile POC  (mPOC) devices. With new mobile and wearable technologies being introduced into the market, there are significant opportunities for deploying new devices that would arguably have higher usage compliance and provide more continuous data for monitoring the health of the user. Some of the challenges are technical (such as developing stable chemistries or reliable image processing), some are related to the relatively uncertain regulatory pathways, and some are at the intersection of user experience and design. This talk will address how to think about overcoming such challenges and will discuss specific case-studies of new technologies that are successfully being brought to the mPOC market in the diabetes and oncology fields.

Add to Calendar ▼2015-01-15 00:00:002015-01-16 00:00:00Europe/LondonPrognostic, Predictive, and POC: Biomarkers from Research to ClinicPrognostic, Predictive, and POC: Biomarkers from Research to Clinic in San Diego, California, USASan Diego, California,